Waverly Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Waverly Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-19,713	Closed	-$150K	–	984
2024 Q3	$150K	Hold	19,713	–	–	﹤0.01%	787
2024 Q2	$122K	Buy	19,713 +2,284	+13%	+$14.1K	﹤0.01%	788
2024 Q1	$88.5K	Sell	17,429 -7,450	-30%	-$37.8K	﹤0.01%	678
2023 Q4	$149K	Hold	24,879	–	–	0.01%	440
2023 Q3	$176K	Hold	24,879	–	–	0.01%	390
2023 Q2	$175K	Hold	24,879	–	–	0.01%	349
2023 Q1	$207K	Hold	24,879	–	–	0.01%	274
2022 Q4	$286K	Hold	24,879	–	–	0.02%	226
2022 Q3	$313K	Sell	24,879 -5,050	-17%	-$63.5K	0.02%	192
2022 Q2	$317K	Buy	29,929 +50	+0.2%	+$530	0.03%	162
2022 Q1	$486K	Hold	29,879	–	–	0.04%	122
2021 Q4	$532K	Hold	29,879	–	–	0.05%	114
2021 Q3	$369K	Hold	29,879	–	–	0.03%	152
2021 Q2	$483K	Hold	29,879	–	–	0.04%	116
2021 Q1	$417K	Buy	29,879 +7,450	+33%	+$104K	0.04%	111
2020 Q4	$206K	Sell	22,429 -1,000	-4%	-$9.19K	0.02%	148
2020 Q3	$89K	Hold	23,429	–	–	0.01%	140
2020 Q2	$108K	Hold	23,429	–	–	0.01%	150
2020 Q1	$47K	Buy	23,429 +1,000	+4%	+$2.01K	0.01%	142
2019 Q4	$67K	Hold	22,429	–	–	0.01%	138
2019 Q3	$64K	Hold	22,429	–	–	0.01%	131
2019 Q2	$85K	Hold	22,429	–	–	0.01%	126
2019 Q1	$183K	Hold	22,429	–	–	0.03%	120
2018 Q4	$181K	Hold	22,429	–	–	0.03%	109
2018 Q3	$171K	Buy	+22,429	New	+$171K	0.03%	184
2018 Q1	–	Sell	-12,132	Closed	-$60K	–	198
2017 Q4	$60K	Buy	+12,132	New	+$60K	0.01%	244
2015 Q4	–	Sell	-3,762	Closed	-$43K	–	154
2015 Q3	$43K	Hold	3,762	–	–	0.03%	153
2015 Q2	$56K	Hold	3,762	–	–	0.03%	123
2015 Q1	$34K	Buy	+3,762	New	+$34K	0.02%	152
2014 Q4	–	Sell	-10,000	Closed	-$98K	–	443
2014 Q3	$98K	Sell	10,000 -10,000	-50%	-$98K	0.05%	141
2014 Q2	$255K	Hold	20,000	–	–	0.11%	95
2014 Q1	$212K	Sell	20,000 -17,600	-47%	-$187K	0.1%	96
2013 Q4	$286K	Buy	37,600 +10,000	+36%	+$76.1K	0.1%	117
2013 Q3	$201K	Hold	27,600	–	–	0.1%	100
2013 Q2	$43K	Buy	+27,600	New	+$43K	0.02%	97